Ward has a PhD in molecular biology research and worked at VIB/UGent, the John Innes Centre and Harvard Medical School. His expertise spans both plant and animal models, and ranges from fundamental to translational research.
Before joining V-Bio Ventures, Ward worked as a senior analyst at Candriam Investors Group, where he was responsible for investment analysis of early-stage listed biotech companies.
Ward holds a PhD in Biotechnology from the University of Gent, Belgium. He also has an MBA from Vlerick Business School, Leuven, Belgium.
